XRCC1 Genetic Polymorphisms and Bladder Cancer Susceptibility: A Meta-analysis

Urology

Volumn 72, Issue 4, 2008, Pages 869-872

  Wang, Chunyang ^a   Sun, Yan ^a   Han, Ruifa ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; HISTIDINE; TRYPTOPHAN; XRCC1 PROTEIN;

ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 52949090764     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.12.059     Document Type: Article

References (16)

1. Murta-Nascimento C., Schmitz-Dräger B.J., Zeegers M.P., et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 25 (2007) 285-295
2. Matullo G., Guarrera S., Sacerdote C., et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14 (2005) 2569-2578
3. Sak S.C., Barrett J.H., Paul A.B., et al. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet 10 (2007) 8-13
4. Masson M., Niedergang C., Schreiber V., et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18 (1998) 3563-3571
5. Figueroa J.D., Malats N., Real F.X., et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 121 (2007) 233-242
6. Andrew A.S., Nelson H.H., Kelsey K.T., et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 27 (2006) 1030-1037
7. Wu X., Gu J., Grossman H.B., Amos C.I., et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78 (2006) 464-479
8. Shen M., Hung R.J., Brennan P., et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12 (2003) 1234-1240
9. Karahalil B., Kocabas N.A., and Ozçelik T. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res 26 (2006) 4955-4958
10. Broberg K., Björk J., Paulsson K., et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 26 (2005) 1263-1271
11. Sanyal S., Festa F., Sakano S., et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
12. Stern M.C., Umbach D.M., van Gils C.H., et al. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10 (2001) 125-131
13. Kiyohara C., Takayama K., and Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54 (2006) 267-283
14. Duell E.J., Millikan R.C., Pittman G.S., et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10 (2001) 217-222
15. Sanyal S., De Verdier P.J., Steineck G., et al. Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol 46 (2007) 31-41
16. Sakano S., Wada T., Matsumoto H., et al. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer 95 (2006) 561-570